To ensure the supply of medical products, the DAD has extended the validity of 10,350 drugs. — Photo courtesy of MOH

HÀ NỘI — The Drug Administration Department (DAD) has extended the licences of 760 drugs and pharmaceutical ingredients until December 31, 2024, bringing the total number of drugs, pharmaceutical ingredients, vaccines, and medical products extended by the Ministry of Health to more than 10,350.

The latest extension marks the third time the DAD granted such an extension in 2023. 

Among the drugs and pharmaceutical ingredients extended this time, 565 were produced domestically, while 195 were foreign drugs.

They cover a wide range of pharmacological effects, including drugs for cancer treatment, cardiovascular diseases, diabetes, antiviral drugs, and common fever-reducing and pain-relieving drugs.

With this extension, the DAD has extended 10,353 drugs, pharmaceutical ingredients, vaccines, and medical products under Resolution 80.

The first round alone saw the Director of the Drug Administration Department extend nearly 8,880 drugs, pharmaceutical ingredients, vaccines, and medical products.

All registration certificates for the extended drugs will continue to be used until December 31st, 2024.

In 2022, the DAD and MOH extended more than 10,000 drugs, pharmaceutical ingredients, vaccines, and medical products.

In addition, on April 2, the Director of the DAD signed a decree to issue registration numbers for the 113th batch of 166 drugs that have been re-registered for three or five years following the provisions of the 2016 Drug Law.

These drugs include antiviral drugs, cancer treatment drugs, and other speciality drugs.

The DAD has previously re-registered many drug items for three or five years following the provisions of the 2016 Drug Law to serve the healthcare and disease prevention needs of the people. — VNS